A biotech research platform using bioluminescent markers for disease detection. Earlier, faster, more accurate.
Engineered luciferase markers that light up specific disease markers. See what was invisible.
Detect cancer markers 6 months earlier than traditional methods. Survival rates improve.
Results in 30 minutes, not 3 days. Point-of-care testing. No lab backlog.
Blood, saliva, or breath samples. No biopsies needed. Painless and fast.
Machine learning models trained on 10M+ samples. Accuracy that improves over time.
Portable devices for clinics worldwide. Bringing early detection to underserved communities.
Biolume has detected early-stage cancer in 4,200+ patients who had no symptoms. Our technology saves lives.
Learn more"Biolume detected my breast cancer 8 months before my mammogram. It saved my life."
"The speed is incredible. 30 minutes for results that used to take 3 days. Game-changer for clinics."
"We deployed Biolume in rural clinics across Africa. Early detection where it was never possible before."